We investigated whether inhibition of nitric oxide (NO) biosynthesis with N-w-nitro-L-arginine (NNA), a competitive inhibitor of NO synthase (NOS), would modify the volume of the focal ischemic infarction produced by occlusion of the middle cerebral artery (MCA) in spontaneously hypertensive rats. NNA was in fused for 1 h (2.4 mg/kg/h) immediately following occlu sion of the MCA. NNA increased lesion volume 24 h later by 32% over controls (150.8 ± 16.6 to 199.2 ± 17.4 mm3; p < 0.001, n = 6). This effect was antagonized by co infusion of L-but not D-arginine. The antihypertensive rilmenidine (0.75 mg/kg) reduced the lesion by 27% (p < 0.05, n = 4). Changes in lesion size were confined to the penumbra. NNA increased arterial pressure (AP) (118 ± There is increasing evidence that the endogenous vasodilator nitric oxide (NO) is synthesized in the brain from the amino acid L-arginine (L-Arg) by the enzyme NO synthase (NOS). The principal form of NOS expressed in brain appears to correspond to the constitutive form of the enzyme (Bredt and Sny der, 1990; Hope et ai., 1991) 
There is increasing evidence that the endogenous vasodilator nitric oxide (NO) is synthesized in the brain from the amino acid L-arginine (L-Arg) by the enzyme NO synthase (NOS). The principal form of NOS expressed in brain appears to correspond to the constitutive form of the enzyme (Bredt and Sny der, 1990; Hope et ai., 1991) , which is rapidly acti vated by elevations in intracellular Ca2+ (Knowles et aI., 1989; Mayer et ai., 1989; Palmer and Mon cada, 1989) . NOS and its message have been local ized to neurons by cytochemistry (Bredt et aI., 1990) , although there is functional evidence that it 8.9 to 149 ± 16.0 mm Hg; p < 0.01, n = 3) but did not change regional CBF. However, elevation of AP did not change the lesion volume or distribution. We conclude that inhibition of the constitutive form of NOS in vivo increases the volume of focal ischemic infarction as a consequence of reduced NO biosynthesis. The absence of NO availability may extend lesion formation by inhibi tion of reactive hyperemia, platelet disaggregation, and/or release of neuroprotective neuromodulators in the pen umbra, which may counteract and override any of its neurotoxic actions. Key Words: Focal cerebral isch emia-Nitric oxide-Nitric oxide synthase-N-w-Nitro L-arginine.
may also be expressed in vascular endothelium and astrocytes (Murphy et aI., 1990) . The other major form of the enzyme, the inducible form (Moncada et aI., 1991) , is preponderantly localized in cells of the immune system, including monocytes and neutro phils. In these cells it is transcribed de novo follow ing exposure of the cell to appropriate stimuli in cluding cytokines (Hibbs et aI., 1990) .
It has recently been proposed that NO may me diate the neurotoxicity produced by the excitatory amino acid L-glutamate (L-Glu) in response to cere bral ischemia (Beckman, 1990 (Beckman, , 1991 Garthwaite, 1991) . The argument derives from several observa tions: (a) First, cerebral ischemia markedly in creases the release of L-Glu (Benveniste et aI., 1984; Hagberg et aI., 1985) . (b) Second, the neuro toxicity of L-Glu results from stimulation of gluta mate receptors of the N-methyl-D-aspartate (NMDA) subclass since treatment with NMDA an tagonists in vitro reduces the cytotoxicity of L-Glu (Rothman and Olney, 1987) and in vivo reduces the magnitude of cerebral damage produced by isch emia (Duverger et aI., 1987; Park et ai., 1988) . (c) Third, activation of the NMDA receptor opens Ca2+ channels, increases the concentration of the intracellular Ca2+ (Siesj6 and Bengtsson, 1989) , and activates NOS, thereby generating more NO (Knowles et aI., 1989) . NO becomes an agent of cytotoxicity. In support of this view are in vitro studies demonstrating that treatments reducing the availability of NO will block the neurotoxicity of L-Glu (Dawson et aI., 1991) .
If the hypothesis is correct, it would be expected that blockade of NO synthesis might therefore be effective in vivo in reducing the size of the infarc tion produced by focal cerebral ischemia. In the present study we have therefore examined the ef fects of inhibition of NOS on the volume of the infarction produced by occlusion of the middle ce rebral artery (MCA) in the rat. That the volume of the infarction can be reduced by various treatments instituted at the time of occlusion has been demon strated by a number of investigations (Park et aI., 1988; Cole et aI., 1989; Reis et aI., 1991) . We report that inhibition of NOS not only failed to reduce the volume of the infarction but significantly in creased it.
MATERIALS AND METHODS
The methods for preparation of rats, for instrumenta tion, for measurement of blood gases, glucose, and he matocrit (Hct), for production of focal cerebral ischemia by occlusion of the MCA, for computation of infarct vol ume, and for recording of regional CBF (rCBF) by laser Doppler flowmetry (LDF) have been described in detail in other publications from our laboratory (Iadecola and Reis, 1990; Reis et at., 1991; Maiese et ai., 1992) and will only be summarized below.
General procedures
Studies were performed on 37 adult male Wistar-Kyoto rats of the spontaneously hypertensive strain weighing 320--390 g. Animals were maintained in a 20°C environ ment and fed laboratory chow ad lib. They were anesthe tized with halothane (1.8-2.5% in 100% O2) blown over the nose. Thin-wall polyethylene (0.965-mm OD) cathe ters were placed in both femoral arteries and one vein. One of the arterial catheters was connected to a Statham P23 db transducer for continuous monitoring of pulsatile and mean arterial pressure (AP) and heart rate on a chart recorder (Grass model 7D). The other arterial line was used for sampling blood (0.2 ml) to determine pH, P02, and Pc02 by a blood gas analyzer (Chiba-Corning model 178), blood glucose (Beckman model 2), and Hct. The venous catheter was employed for administration of agents.
Following instrumentation, rats were mounted in a Kopf stereotaxic apparatus. Body temperature was con tinuously monitored and maintained at 37°C by a thermo statically controlled infrared lamp connected to a rectal J Cereb Blood Flow Metab, Vol. 12, No. 5, 1992 probe. Arterial blood was sampled before and after (45 min) MCA occlusion for blood gases, Hct, and glucose.
Occlusion of MCA
The MCA was exposed for occlusion distal to the len ticulostriatal branches by a method (Reis et at., 1991) modified from that of Tamura et al. (1981) . Animals were rotated in the stereotaxic frame to a lateral position with the right side facing upward. The skin was incised mid way between the orbit and external auditory meatus and the temporal muscle was retracted. Under magnification, the MCA was exposed through a hole in the skull at a point rostral to the fusion of the zygomatic arch and squa mous bone made with a dental drill continuously cooled with saline drip. The dura overlying the MCA was in cised. A small wire hook was inserted under the MCA just superior to the inferior cortical vein and the artery was cauterized. To avoid recanalization. the MCA was then transected. The same surgeon was responsible for production of all lesions.
Immediately following MCA occlusion, agents were administered intravenously with AP maintained within the autoregulated range (Dirnagl and Pulsinelli, 1990) , if necessary, by infusion of phenylephrine (PHE). After 1 h, the cranial wound was covered with Gelfoam (Upjohn) and closed with sutures. The animal was removed from the stereotaxic frame, and the femoral arterial and venous catheters were removed after ligation of the vessels. The anesthesia was discontinued and the animal was returned to its cage. The duration of each experiment was � 3 h.
Computation of infarct volume
Twenty-four hours later, animals were reanesthetized with halothane and killed by decapitation. The brains were removed, immediately frozen in liquid Freon, and stored at -20°C until analysis, usually within 1 week. Brains were serially sectioned at 20 f.Lm in a cryostat mi crotome at -20°C in the coronal plane. Sections were sampled every 200 f.Lm and stained with thionin. Each section was identified by reference to corresponding lev els in the atlas of rat brain by Paxinos and Watson (1986) and was projected onto a data tablet. The boundary of the infarct was defined by the sharp delineation, on thionin stained sections, of the near-complete loss of staining of Nissl substance. The borders of the lesion were usually self-evident, but when questionable were verified micro scopically. The cross-sectional area was digitized and computed by tracing the lesion on MCID software (Im aging Research, St. Catharines. Ontario, Canada). The volume of the infarct was calculated as the product of cross-sectional area for all sections and distance between sections.
Monitoring of rCBF by LDF rCBF was measured in rats without MCA occlusion by LDF. This method permits continuous recording of rCBF in vivo (Dirnagl et aI., 1989) . LDF was performed with a PeriFlux PF3 (Perimed) flowmeter with flow values as perfusion units and changes in rCBF were expressed as percentage change in flow. A hole 1 mm in diameter was drilled through the skull 2.0 mm lateral to the midline and 7.2 mm rostral to the interaural line. This corresponds to the area that was most affected in other animals by MCA occlusion. The dura was left intact. Following the appli-cation of mineral oil to the hole, the probe (dental probe, model PF 303) was positioned -0.5 mm above the dural surface. Care was taken to avoid bleeding from the bone or dura as well as exposure of probe to direct light since these can reduce the flow signal. At times, it was neces sary to reposition the probe 0.3 mm rostrally or caudally to avoid placement over large pial vessels (>500 f.lm) that invalidate the LDF flow signal (Haberl et aI., 1989) . The analog output from the LDF was displayed on a polygraph (Grass model 7D). Cerebrovascular resistance (CVR) was calculated as CVR = systemic mean AP/ rCBF and expressed as percentage change of CVR.
Experimental groups and statistics
The animals (n = 37) were divided into seven groups of three to six rats: In one group only the MCA was oc cluded (MCA control; n = 6); in four more groups rats with MCA occlusion received either (a) N-w-nitro-L arginine free base (NNA; 0.04 mg/kg/min x 60 min i.v.; n = 6) (Sigma, St. Louis, MO), (b) NNA and L-arginine free base (3.5 mg/kg/min x 60 min i.v.; n = 6) (Sigma), (c) NNA and D-arginine hydrochloride (3.5 mg/kg/min x 60 min i.v.; n = 6) (Sigma), or (d) the antihypertensive ox azole rilmenidine (RIL; 0.75 mg/kg i.v.; n = 4). In an other group following MCA occlusion AP was elevated for 1 h with PHE (0.194-1.94 f.lg/kg/min x 60 min i.v.; n = 6). In an additional group rCBF was monitored in rats without MCA occlusion receiving NNA (0.04 mg/kg/min x 60 min i.v.; CBF study; n = 3).
In general, physiological variables were comparable between groups (Table 1) except for a modest hypercar bia in the NNA, NNA + L-Arg, and RIL groups. AP varied between groups as described in text.
Data were evaluated by one-way analysis of variance (Tables 1 and 2 ), or by two-way analysis of variance) (see Fig. 3 ). Two-group comparisons were analyzed by the Newman-Keuls test (Fig. I) , the unpaired Student t test (Tables I and 2) , and the paired t test (Fig. 3 ). Differences were considered significant for p < 0.05.
RESULTS

Effect of RIL on focal cerebral ischemia
In the first study we compared the effect upon the volume and distribution of the focal infarctions pro duced by occlusion of the MeA in untreated rats with that in those treated with RIL. RIL is a anti hypertensive oxazole that we have previously dem onstrated is capable of reducing the volume of focal ischemic infarction by � 32% (Maiese et aI., 1992) . The object of the experiment was to demonstrate, given the variability of lesions produced between and within rat strains (Brint et aI., 1988; Duverger and MacKenzie, 1988; Reis et aI., 1991) , that under the conditions of our experiment, lesion size could be reduced by pharmacological intervention.
Occlusion of the MeA in the control group (n = 6) resulted in a well-recognized ischemic infarction (see Fig. 2 ) within the territory of the MeA. The lesion extended over 12 mm from the frontal to the occipital cortex as demonstrated in Fig. 1 . Laterally (Fig. 2) , the lesion extended over the dorsal portion of the hemisphere to preserve cingulate and adja cent motor cortex and ventrally to include pyriform cortex. Medially, the infarct involved the lateral edge of the caudate and putamen and the internal capsule. Notable was the great uniformity of the distribution and small variability of the cross-TABLE 1. Mean ± SD values of mean arterial pressure (AP), blood gases, hematocrit (Hct), and blood glucose in different treatment groups before or 45 min after occlusion of middle cerebral artery (Maiese et al., 1992) , RIL re duced the volume of the lesion by 27% ( Table 2 ). The distribution of the salvage was confined to the caudal half of the lesion (Fig. lA) with maximum cross-sectional area of 19. 7 mm2 obtained 8.8 mm anterior to the interaural line. The distribution of the salvage is depicted at the cross-sectional area in Fig. 2 . The maximal zone of recovery was con tained within the penumbra lying in ventral and dor sal portions of the parietal cortex, medially in the caudate putamen and the internal capsule, and cau dally in the occipital cortex.
Effect of inhibition of NO synthesis by NNA on focal cerebral ischemia NN A (0.04 mg/kg/min) was continuously admin istered for 1 h immediately following occlusion of the MeA in six rats. NN A increased the volume of the lesion by 32% (Table 2; Fig. lB ) . The maximum cross-sectional area of 26.8 mm2 was located 8.0 mm anterior to the interaural line. The distribution of the lesion was similar to that of the control group but extended dorsally, ventrally, and medially into the penumbral zone (Fig. 2) . Thus, more of the dor sal and ventral hemisphere, medially portions of the hippocampal formation, the corpus callosum, and a significant portion of the caudate putamen, rostrally the orbital cortex, and caudally the occipital cortex were involved.
To assess whether the effect of NNA on enlarging the lesion was attributable to inhibition of NOS by competition for the substrate, L-arginine (210 mg/ Fig. 3 ). The increase was gradual with the elevation detected at 30 min following the beginning of the infusion, peaking at 120 min (average increase 31.5 mm Rg) and gradually declining to control values (Fig. 3) . To evaluate the effect of the elevated systemic AP upon the size of the focal ischemic lesion, AP was elevated in six rats with PRE to levels comparable with those produced by NN A ( Table 1) . Elevation of AP, in agreement with our previous results (Maiese et al., 1992) , had no effect upon the size or distribution of the infarction produced by MCA oc clusion (Table 2; Fig. ID) .
To determine whether the dose of NN A modified rC BF, which enlarged the infarct (0.04 mg/kg/min x 60 min), rC BF was measured by LDF over the pa rietal cortex in three rats not subjected to MCA occlusion. AP was measured and regional CVR computed. NNA elicited a rise in AP peaking at 120 min. In contrast, rCBF was unchanged as a conse quence of an increase in CVR (Fig. 3) . The results demonstrate that the dose used was sufficient to elevate AP and CVR, that cerebrovascular autoreg ulation was preserved, and that the drug did not result in a reduction in cerebrovascular perfusion.
DISCUSSION
In the present study, we have examined the effect of inhibition of NOS in rat on the size of a focal ischemic infarction produced by occlusion of the MCA (Tamura et al., 1981) . The rationale of the study was based on the premise that damage of neu rons in the penumbra of a focal ischemic infarction may result from liberation, by ischemia, of L-GlU (Olney and Sharpe, 1969; Benveniste et al., 1984; Choi, 1990) . L-Glu, acting through the NMDA sub type of L-Glu receptor (Rothman and Olney, 1987; Siesjo and Bengtsson, 1989) , will, by increasing in tracellular Ca2 +, activate the constitutive form of (MCA occlusion only; n = 6), rilmenidine-treated (RIL; 0.75 mg/kg; n = 4), and N-w-nitro-L-arginine-treated (NNA; 2.4 mg/kg/h for 1 h; n = 6) animals. This figure illustrates the superimposed distribution of all animals in each group at representative levels (13.7, 11.7, 9.7, 5.7, 3.7 , and 1.7 mm from interaural line). The dark and light stipple and hatched area represents extension of lesion in the NNA group. The light stipple and hatched area is distribution in the control animals. The light stipple region shows lesion in the RIL animals. The dark stipple area therefore represents the aggravated zone with NNA administration. The hatched area is the distribution of salvage with RIL.
NOS (Knowles et ai., 1989; Mayer et ai., 1989; Palmer and Moncada, 1989) , resulting thereby in enhanced biosynthesis of NO (Garthwaite et ai., 1988 (Garthwaite et ai., , 1989 Southam et ai., 1991 may act as a neurotoxic mediator destroying neu rons (Beckman, 1990 (Beckman, , 1991 Garthwaite, 1991) . In support of this hypothesis are the observations in vitro that the neurotoxicity of L-Glu is inhibited by interfering with the production or actions of NO (Dawson et al., 1991) . On this basis it would be predicted that inhibition of NOS would be effective in limiting the size of the ischemic injury.
In contrast with the prediction, we have observed that inhibition of NOS with the competitive inhibi tor NNA not only failed to reduce the size of the focal infarction, but increased it. The inability of the agent to protect against ischemic infarction cannot be attributed to the inability of any treatment to reduce penumbral damage or to the inadequate tim ing of the treatment. Actually, in agreement with our previous study (Maiese et al., 1992) , the ox azole RIL, which was administered in place of NNA, was capable of reducing infarct size by 27%. Nor can the failure be attributed to an inability of the drug to penetrate brain since present evidence suggests that the agent penetrates the blood-brain barrier (Dwyer et al., 1991) . Also, it is unlikely that the failure of NNA to offer protection from MCA occlusion can be attributed to physiological vari ables. There were few differences among groups except for small increases in Peoz and mean AP after MCA occlusion in some groups. Neither hy pertension nor hypercarbia within this range will modify the size of focal cerebral infarctions (Maiese et al., 1992) .
The increase in cerebral damage elicited by inhi bition of NOS was localized to a region surrounding the core of the infarction and corresponding to the penumbral zone of cerebral ischemia (Nedergaard et al., 1986) . That the enlargement is attributable to competitive inhibition of NOS by NNA is sup ported by the finding that it can be reversed by co-administration of L-but not o-arginine (Rees et al., 1989) . It also demonstrates, in agreement with some other results (Osborne et al., 1987; Duverger and MacKenzie, 1988; Cole et al., 1990; Maiese et al., 1992) , that the size of the focal ischemic infarc tion obtained by MCA occlusion is not at a "ceil ing" but can be enlarged by some treatments.
The mechanism by which inhibition of NO syn thesis increases the volume of the ischemic infarc tion must therefore result from interference with NO-mediated cellular events that are neuroprotec tive in vivo, including the action of NO on local vascular perfusion, platelet aggregation, and/or syn aptic transmission.
While a continuous low background release of NO from endothelium is believed to provide a tonic level of vasodilation (Aisaka et al., 1989) , it is un likely that enlargement of the focal ischemic lesion by NN A is related to reduction of basal rCBF. Thus, while inhibition of NOS led to the well documented elevation in AP (Aisaka et al., 1989; 1 990a ,b), we did not observe any re duction of rCBF as measured by LDF in control animals under the conditions and doses of this study. The maintenance of rCBF was a conse quence of an increase in CVR, indicating that cere brovascular autoregulation was still intact. The fail ure of NNA to modify resting rCBF is in accord with other observations from this laboratory, which have demonstrated that comparable amounts of NNA administered systemically or by cortical su perfusion (E. V. Golanov et al., in preparation) fail to modify rCBF until doses are supermaximal for the peripheral vasoconstriction. While Tanaka et al. (1991) have recently reported that the intravenous administration of high doses of the NOS inhibitor N-monomethyl-L-arginine will lower rCBF mea sured by the autoradiographic method in animals without occlusion of major cerebral vessels, the doses utilized in that study were well above those used here.
On the other hand, NO liberated from hypoxic endothelium (Brenner et aI., 1989 ) may be of impor-tance in producing a reactive hyperemia counteract ing the reduction of rCBF in the lesion. This hyper emia may sustain perfusion in the penumbra; and even though local flow may still lie below normal values, it may be sufficient to sustain marginal neu ronal viability. That the impairment of such a mech anism may explain the extension of the lesion after inhibition of NOS is supported by the fact that re moval of vasodilator inputs to an area of focal isch emia produced by MCA occlusion can also lead to enlargement of the lesion (Kano et a!., 1991) .
Another mechanism through which NO would be neuroprotective relates to the fact that NO facili tates platelet disaggregation (Radomski et a!., 1987a,b; Sneddon and Vane, 1988) and reduces the formation of microthrombi. That platelet-activated microthrombosis may produce or enhance focal ce rebral infarction under controlled experimental con ditions has been demonstrated (Fieschi et a!., 1975; Furlow and Bass, 1976; Dietrich et a!., 1986 Dietrich et a!., , 1987 .
Finally, another protective mechanism relates to the prospect that impairment of NO production by NNA may modulate the activity and/or signal trans duction of other neurotransmitter systems acting upon vulnerable neurons. NO has been proposed to modulate the release of several neurotransmitters (Moncada et aI., 1989; Toda and Okamoto, 1990; Crossin, 1991) , some of which may counteract the action of L-Glu. That neurotransmitter-regulated events may play a role in neuroprotection in focal cerebral infarction has been demonstrated by the observation that focal ischemic infarction elicited by occlusion of the MCA in rat may be reduced by almost 50% by excitation of intrinsic neuronal net works related to the cerebellar fastigial nucleus (Berger et a!., 1990; Reis et a!., 1991) .
Since completion and submission of this study, Nowicki et al. (1991) have reported that inhibition of NOS by NNA will reduce the volume of the le sion produced by occlusion of the MCA in mouse. In that study, the drug was administered intraperi toneally several times over 2 days. Why our result should differ from that of Nowicki et ai. (1991) , other than a consequence of species difference, is not clear. However, it should be noted that in our study NNA was administered as a single dose at the time of vascular occlusion. Since the duration of action of the drug on vascular NOS (as indicated by the effect on AP) is of the order of 3 h, the effect of the inhibition will be restricted to the constitutive form of the enzyme. On the other hand, the repet itive dosages of NNA over 1 day would inhibit any NOS of the inducible form that might be activated over many hours in macrophages and monocytes (Moncada et aI., 1991) , which rapidly invade and J Cereb Blood Flow Metab, Vol. 12, No.5, 1992 proliferate in lesioned brain (Katz et aI., 1990) . In ducible NOS might also be expressed in astrocytes, which we have recently demonstrated in primary culture (E. Galea et aI., in preparation). Thus, it is conceivable that NO synthesized from the inducible form of the enzyme, whose inhibition leads to neu roprotection when treatment is extended after the initial insult, might be neurotoxic, while inhibition of the constitutive form of the enzyme, as in our protocol, would interfere with indirect neuroprotec tive events mediated by NO, including reactive hy peremia and platelet disaggregation.
The study therefore demonstrates that despite the findings in vitro that inhibition of the generation of NO from NOS may protect neurons from the neu rotoxicity of L-Glu (Dawson et aI., 1991) , in vivo inhibition of the enzyme is not only nonprotective but deleterious. The difference between the in vitro and in vivo models most likely reflects the complex ity and multicellular actions of NO (Moncada et aI., 1991) . Conceivably, by impairing actions of NO in promoting reactive hyperemia, platelet disaggrega tion, and even the actions of neuroprotective neu rotransmitter systems, the net result of treatment with NOS inhibitors in focal ischemia promotes brain damage. Acute blockade of NOS is unlikely to be of therapeutic utility in the treatment of ischemic stroke. However, conceivably initiation of tran scription of the inducible form of NOS, which might lead to delayed release of NO, may participate in some pathological processes and might be a useful therapeutic target for NOS inhibition.
